The Hirshberg Foundation is excited to have Dr. Randall E. Brand join us at the 13th Annual Symposium on Pancreatic Cancer to discuss the role that genetics play in pancreatic cancer.
Randall E. Brand, MD, is a Professor of Medicine and a physician-scientist with an extensive background in pancreatic diseases mainly focused on the early diagnosis of pancreatic cancer and cystic lesions of the pancreas. His research also involves familial pancreatic cancer and other hereditary GI disorders. He is leader of the University of Pittsburgh’s Pancreatic Adenocarcinoma Gene Environment Registry (PAGER). The biospecimen repository developed as part of the PAGER study is nationally recognized and serves as an excellent resource for multiple NIH/NCI funded projects along with national and international collaborations with outside researchers. He is a key contributor to the Early Detection Research Network, especially in research related to pancreatic cancer and cystic neoplasms. He is currently funded in the network as a principal investigator to lead both a multi-center Pancreatic Cancer Clinical Validation Center and Biomarker Developmental Laboratory.
Dr. Brand’s clinical practice focuses on the management of pancreatic cancer, cystic lesions of the pancreas and patients with other gastrointestinal (GI) cancers. As director of the Hereditary GI Tumor Program, Dr. Brand specializes in the management of individuals at high risk for the development of colon cancer, pancreatic cancer and other GI malignancies. Dr. Brand works closely with genetic counselors who have an expertise in the evaluation of individuals with a GI cancer predisposition based on personal and family history.
We are excited to have Dr. Brand with us to address Is it all in the Genes? when it comes to pancreatic cancer at the 13th Annual Symposium at UCLA.
